MedSIR will be there: ASCO GU
MedSIR will be making its second straight appearance at the annual ASCO GU Congress, this time held under the beautiful California sunshine in San Francisco.
With MedSIR growing very steadily in the domain of Breast Cancer, carrying out various multinational trials of over 300 patients each, it is time to set our sights on new horizons. The domain of Genitourinary Tumors is very appealing with the arrival of a multitude of new agents, whether novel TKIs or Immunotherapies. Renal Cell Cancer is a perfect example of the successful arrival of innovative medicines, but great things are also happening in Prostate and Bladder Cancer.
We are very excited about what may lie ahead for us in this domain, which is full of exciting new companies, compounds, and bright minds searching to come up with the next great idea for groundbreaking research that will hopefully translate into benefitting numerous patients worldwide.
If you are researcher or company in the GU domain and you are looking for help to develop your research ideas, don’t miss out on the chance to meet with MedSIR next month at ASCO GU.